1. Active specific immunotherapy of renal cell carcinoma patients: a prospective randomized study of hormono-immuno-versus hormonotherapy. Preliminary report of immunological and clinical aspects;Adler;Journal of Biological Response Modifiers,1987
2. SC-interleukin-2 and SC-interferon-alpha therapy in combination with IV-5-fluorouracil in metastatic renal cell carcinoma;Anton;J Urol,1996
3. A randomized clinical trial comparing sc interleukin-2, sc alpha-2a-interferon, and iv bolus 5-flurouracil against oral tamoxifen in progressive metastatic renal cell carcinoma patients;Atzpodien;Eu J Cancer,1997
4. Results of a randomized clinical trial comparing SC interleukin-2, SC alpha-2a-interferon, and IV bolus 5-fluorouracil against oral tamoxifen in progressive metastatic renal cell carcinoma patients;Atzpodien;Proc ASCO,1997
5. A randomized phase II trial of recombinant human interleukin-12 versus interferon alpha-2a in advanced renal cell carcinoma;Berg;Proc ASCO,1998